This Headway company profile covers the company's valuation, revenue, funding rounds, investors and history. Headway works in healthcare, with a focus on mental health provider network. It was founded in 2019 and is headquartered in New York, New York, United States. Its latest valuation on record is US$2.3 billion (July 2024). Every figure links to a public source, and anything the company hasn't disclosed is marked as such.
Revenue
| Metric | Value | As of | Source |
|---|---|---|---|
| Total funding | More than US$321 million raised to date (as reported) | July 2024 | Fierce Healthcare |
Funding history
| Date | Round | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jul 2024 | Series D | US$100M | US$2.3B | Spark Capital (lead); Thrive Capital, Accel, Andreessen Horowitz, Forerunner Ventures | MobiHealthNews |
Headway timeline
Key dates from the sources on this page, oldest first. Metric snapshots are listed after the funding events.
- 2019 — Headway is founded in New York by Andrew Adams (CEO) and co-founders.
- Jul 2024 — Series D: US$100M, valuing the company at US$2.3B. Investors: Spark Capital (lead); Thrive Capital, Accel, Andreessen Horowitz, Forerunner Ventures.
- July 2024 — Total funding: More than US$321 million raised to date (as reported).
Investors
Overview
Headway is building a national network of therapists and psychiatric providers who accept health insurance. In the US, many therapists don't take insurance because dealing with insurers is complicated: credentialing takes months, billing is time-consuming, payments can be slow and reimbursement rates may be low. As a result, many patients pay out of pocket or go without care. Headway handles credentialing, billing and payments for providers, often paying them quickly and at competitive rates, so they can accept insurance without the administrative burden. Patients use Headway to find in-network providers and pay only their usual copays. In July 2024 it raised US$100 million at a US$2.3 billion valuation.
Andrew Adams, the CEO, co-founded Headway in 2019 in New York. Adams previously worked at technology companies and became interested in mental health access after experiencing the difficulty of finding affordable therapy. The founders set out to fix the system by working with insurers and providers rather than building a cash-pay alternative.
Products
- Provider platform: credentialing with insurers, scheduling, billing, claims and payments for therapists and psychiatric providers.
- Patient search: a directory to find in-network providers by location, specialty and insurance.
- Practice tools: notes, measurement tools and support for running a private practice.
- Insurer partnerships: agreements with commercial insurers and, increasingly, Medicare Advantage and Medicaid plans.
Funding
Headway raised earlier rounds from investors including Accel, Andreessen Horowitz, Thrive Capital and Spark Capital. In July 2024 it raised a US$100 million Series D led by Spark Capital, with Thrive Capital, Accel, Andreessen Horowitz and new investor Forerunner Ventures, at a US$2.3 billion valuation, about 130% higher than nine months earlier. The company said the funds would accelerate expansion to serve people with Medicare Advantage and Medicaid coverage. Reports put total funding at more than US$320 million.
Business model
Headway negotiates rates with insurers and pays providers, earning revenue from the difference and from fees tied to claims. Providers don't pay to join, which helps it grow its network rapidly. Insurers benefit because Headway expands their networks of available mental health providers, an area where regulators and employers have pressured plans to improve access. Its margins depend on rates negotiated with insurers and the volume of sessions.
Competition
Headway competes with Alma, Grow Therapy, Rula and SonderMind, which also help providers accept insurance; with employer benefits providers such as Lyra Health and Spring Health; and with cash-pay platforms such as BetterHelp and Talkspace. Its advantages are a large provider network, insurer relationships and a provider-friendly approach.
Headway at a glance
Headway is a New York mental health company founded in 2019 by Andrew Adams and co-founders. It helps therapists accept insurance by handling credentialing, billing and payments, and helps patients find in-network care. It raised a US$100 million Series D in July 2024 led by Spark Capital at a US$2.3 billion valuation, with plans to expand into Medicare Advantage and Medicaid.
Timeline
- 2019: founded in New York.
- 2020–2022: grows its provider network nationally.
- 2023: raises a Series C.
- July 2024: raises US$100 million at US$2.3 billion.
- 2024–2025: expands into Medicare Advantage and Medicaid.
The insurance gap in mental health
Studies and surveys have long shown that mental health providers participate in insurance networks at lower rates than other clinicians, partly because of low reimbursement and paperwork. Patients face "ghost networks", directories listing providers who aren't actually taking new patients. US mental health parity laws require insurers to cover mental health similarly to physical health, and regulators have pushed for better access. Headway's model aims to make it worthwhile for providers to join networks, increasing real access for patients with insurance.
Medicare and Medicaid
Medicare Advantage and Medicaid cover tens of millions of Americans, including older adults and people with low incomes, many of whom struggle to find mental health care. Medicare began covering services from licensed marriage and family therapists and mental health counsellors in 2024, expanding the pool of eligible providers. Credentialing for these programmes can be particularly slow, which is why Headway is building tools to speed it up.
Who uses Headway
Headway's users include therapists, counsellors, psychologists and psychiatric providers in private practice, and patients with commercial insurance, Medicare Advantage or Medicaid who want in-network mental health care.
Valuation context
Headway's valuation more than doubled in nine months, a sign of investor confidence when many digital health companies struggled. Its insurance-based model differs from cash-pay competitors that saw demand fall after the pandemic.
Risks
- Insurer rates: reimbursement cuts would hurt margins and provider supply.
- Competition: several well-funded companies use similar models.
- Regulation: billing and compliance requirements are complex.
Questions for providers
- Which insurers can you be credentialed with, and how long does it take?
- What rates and payment timelines apply?
- Do you keep ownership of your practice and patient relationships?
How Headway helps a typical therapist
A newly licensed therapist starting a private practice might want to accept insurance to reach more clients, but credentialing with each insurer can take months of paperwork, and once in network, they must submit claims, chase denials and wait for payments. Headway handles credentialing with multiple insurers, submits claims on the therapist's behalf and pays them on a predictable schedule, so they can focus on clinical work. Clients find the therapist through Headway's directory, confirm coverage and pay their normal copay. For therapists, this can make insurance-based practice financially viable; for clients, it makes care more affordable. The model depends on Headway securing rates with insurers that are attractive enough for providers while leaving room for its own margin.
Who funds Headway
Headway's investors include several of the best-known US venture firms, among them Spark Capital, Thrive Capital, Accel, Andreessen Horowitz and Forerunner Ventures, reflecting confidence in the insurance-based approach to mental health access.
Latest developments (October 2026)
Headway has not announced new funding since 2024. In 2026 it introduced biometric identity verification for patients of prescribing clinicians and acquired the team behind AI company Tezi to strengthen its engineering, according to public company updates. The latest valuation in this profile, about US$2.3 billion, is an estimate tied to 2024 activity. See our mental health startups guide.
What to watch
Watch Medicaid and Medicare expansion, new funding and competition with Alma, Grow Therapy and Rula. Our guide to healthcare AI startups covers related companies.
Takeaways
Patients can find therapists who accept their insurance. Providers can accept insurance without the paperwork burden. Investors should watch insurer rates and competition.
Sources
Every figure on this page comes from the public sources below. Where sources disagreed, we used the company's own announcement or a primary news report. Private-company data changes; check the date beside each figure.
Frequently asked questions
What does Headway do?
Headway is a healthcare / mental health provider network company headquartered in New York, New York, United States. It was founded in 2019.
What is Headway's valuation?
Headway was valued at US$2.3 billion as of July 2024, according to Fierce Healthcare. Private company valuations are set at funding rounds or share sales and can change significantly between them.
How much revenue does Headway make?
Headway is a private company and has not publicly disclosed its revenue. Figures on third-party sites are usually modelled estimates rather than numbers reported by the company.
What was Headway's latest funding round?
The most recent financing we have verified is a series d in Jul 2024: US$100M, at a valuation of US$2.3B. Source: MobiHealthNews.
Who are Headway's investors?
Investors named in public announcements include Spark Capital, Thrive Capital, Accel, Andreessen Horowitz and Forerunner Ventures.
Who founded Headway?
Headway was founded in 2019 by Andrew Adams (CEO) and co-founders.
Is Headway a public company?
No. Headway is a private company (private, venture backed), so its shares are not traded on a stock exchange and it isn't required to publish its financial results.
Where is Headway headquartered?
Headway is headquartered in New York, New York, United States.